Multidrug resistance activity in human lymphocytes
- PMID: 1720770
- DOI: 10.1016/0198-8859(91)90110-u
Multidrug resistance activity in human lymphocytes
Abstract
The multidrug resistance gene (mdr1) is a member of the recently described ATP binding cassette (ABC) superfamily of transporters. Family members include: (1) the cystic fibrosis transmembrane conductance regulator gene; (2) the hlyB gene of bacteria, and (3) the histocompatibility antigen modifier (HAM) gene. The level of expression of mdr1 correlates with multidrug resistance (MDR), the ability of cells to efflux otherwise toxic doses of several chemotherapeutic agents. MDR activity is also associated with the efflux of cationic lipophilic compounds such as the fluorescent dye rhodamine 123. Recently it was reported that normal lymphocytes efflux rhodamine 123, suggesting that these cells possess MDR-like activity due to the expression of mdr1. In this study, using two-color flow cytometric analysis, we observed that the ability to efflux rhodamine 123 was heterogeneous among human lymphocyte subsets in the order of CD8 greater than CD4 greater than CD2O. Rhodamine 123 efflux and accumulation in lymphocytes was sensitive to the known MDR reversing agents, verapamil and Solutol HS 15. Collectively, these data suggest that an MDR-like transport system is present in normal lymphocytes and may be important for trafficking of molecules involved in lymphocyte function.
Similar articles
-
Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.Blood. 1992 Dec 1;80(11):2735-9. Blood. 1992. PMID: 1360267
-
Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.J Natl Cancer Inst. 1993 Nov 3;85(21):1751-8. doi: 10.1093/jnci/85.21.1751. J Natl Cancer Inst. 1993. PMID: 8105101
-
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells.Cancer Immunol Immunother. 1993;36(2):133-9. doi: 10.1007/BF01754414. Cancer Immunol Immunother. 1993. PMID: 8093856 Free PMC article.
-
Multidrug resistance: molecular mechanisms and clinical relevance.Cancer Chemother Pharmacol. 1997;40 Suppl:S3-8. doi: 10.1007/s002800051053. Cancer Chemother Pharmacol. 1997. PMID: 9272126 Review.
-
P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.Biochim Biophys Acta. 1992 Jul 7;1139(3):169-83. doi: 10.1016/0925-4439(92)90131-6. Biochim Biophys Acta. 1992. PMID: 1352705 Review.
Cited by
-
Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis.Mucosal Immunol. 2013 Mar;6(2):309-23. doi: 10.1038/mi.2012.73. Epub 2012 Aug 8. Mucosal Immunol. 2013. PMID: 22874899 Free PMC article.
-
P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection.J Clin Immunol. 1993 Sep;13(5):289-301. doi: 10.1007/BF00920237. J Clin Immunol. 1993. PMID: 7902361 Review.
-
Architecture of Chimeric Spheroids Controls Drug Transport.Cancer Microenviron. 2015 Aug;8(2):101-9. doi: 10.1007/s12307-015-0171-0. Epub 2015 Aug 4. Cancer Microenviron. 2015. PMID: 26239082 Free PMC article.
-
The MDR1 (ABCB1) gene polymorphism and its clinical implications.Clin Pharmacokinet. 2004;43(9):553-76. doi: 10.2165/00003088-200443090-00001. Clin Pharmacokinet. 2004. PMID: 15217301 Review.
-
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.Cancer Chemother Pharmacol. 1994;34(6):459-64. doi: 10.1007/BF00685655. Cancer Chemother Pharmacol. 1994. PMID: 7923555
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials